Pressure BioSciences, Inc. and Crème de Canna announced their commercial agreement for the supply and distribution of PBIO's UltraShearâ¢-processed nanoemulsified CBD ("UltraShear Nano-CBD") in a hemp-derived, best-in-class, super-fast acting, highly bioavailable, all natural, preservative-free, and highly potent (40 mg/ml) Nano-CBD Topical Spray.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1202 USD | -5.58% | +0.17% | -63.58% |
1st Jan change | Capi. | |
---|---|---|
-63.58% | 4.17M | |
-6.24% | 180B | |
-6.39% | 98.89B | |
-5.97% | 66.26B | |
-9.61% | 44.61B | |
+8.84% | 44.02B | |
+9.84% | 40.12B | |
+12.69% | 29.19B | |
+12.98% | 23.41B | |
-7.83% | 23.64B |
- Stock Market
- Equities
- PBIO Stock
- News Pressure BioSciences, Inc.
- Pressure BioSciences, Inc. Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Creme de Canna